Immunohistochemical Characterization of Hepatic Lymphocytes in Primary Biliary Cirrhosis in Comparison With Primary Sclerosing Cholangitis and Autoimmune Chronic Active Hepatitis

We analyzed the immunophenotypes of hepatic cellular infiltrates by quantitative immunohistochemical methods in biopsy specimens from 20 patients with primary biliary cirrhosis (PBC), 19 with primary sclerosing cholangitis, and 11 with autoimmune chronic active hepatitis. Specifically, we sought to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mayo Clinic proceedings 1993-11, Vol.68 (11), p.1049-1055
Hauptverfasser: HASHIMOTO, ETSUKO, LINDOR, KEITH D., HOMBURGER, HENRY A., DICKSON, E. ROLLAND, CZAJA, ALBERT J., WIESNER, RUSSELL H., LUDWIG, JURGEN
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1055
container_issue 11
container_start_page 1049
container_title Mayo Clinic proceedings
container_volume 68
creator HASHIMOTO, ETSUKO
LINDOR, KEITH D.
HOMBURGER, HENRY A.
DICKSON, E. ROLLAND
CZAJA, ALBERT J.
WIESNER, RUSSELL H.
LUDWIG, JURGEN
description We analyzed the immunophenotypes of hepatic cellular infiltrates by quantitative immunohistochemical methods in biopsy specimens from 20 patients with primary biliary cirrhosis (PBC), 19 with primary sclerosing cholangitis, and 11 with autoimmune chronic active hepatitis. Specifically, we sought to identify activated T cells, interferon-γ-producing cells, and natural killer cells. The portal cellular infiltrate in PBC contained a preponderance of CD4 cells in comparison with CD8 cells, with a CD4/CD8 ratio of 2.45:1. The cellular infiltrate in areas of piecemeal necrosis contained mostly CD8 cells. Infiltrating CD8 cells in PBC had the surface phenotype of cytotoxic (CD8-positive, CD11b-negative) cells. Approximately 4% of T cells expressed interleukin 2 receptors. Interferon-γ-staining cells were rarely identified (in less than 2%). cells that expressed the natural killer cell markers CD16, CD56, or CD57 were infrequent, constituting approximately 5% of the cellular infiltrate. The composition of the infiltrates was similar in patients with PBC and chronic active hepatitis. Natural killer cells were twice as common in patients with primary sclerosing cholangitis (P
doi_str_mv 10.1016/S0025-6196(12)60897-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76060413</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0025619612608970</els_id><sourcerecordid>76060413</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-698cb3ac426b6a72ba1039e55c2d8fa8c33e80b747f4f67a85574a10a6b2ad973</originalsourceid><addsrcrecordid>eNqFkd2K1EAQhRtR1nH1ERZyIaIX0f5JOsmVzAb3BwYUVvGy6XQqm5IkHbs7C-Nj-YT2zIS59aoazldVp_oQcsXoR0aZ_PRAKc9TySr5nvEPkpZVkdJnZMOqjKd5nsnnZHNGXpJX3v-ilBZVlV2Qi5ILxmW5IX_vx3GZbI8-WNPDiEYPSd1rp00Ah390QDsltkvuYI5vk-z249xbsw_gE5ySbw5H7fbJNQ54qDU611uPR7G246wd-jjhJ4b-DD-YAVyEpse4yg56esQQO_TUJtslWDxYgig5O8WNWxPwCVYDkXtNXnR68PBmrZfkx82X7_Vduvt6e19vd6kRZRVSWZWmEdpkXDZSF7zRjIoK8tzwtux0aYSAkjZFVnRZJwtd5nmRRUbLhuu2KsQleXeaOzv7ewEf1IjewBD9gl28KiSVNGMigvkJNPEo76BT8-lQxag6ZKWOWalDEIpxdcxK0dh3tS5YmhHac9caTtTfrrr2MZbO6cmgP2MicvLo8_MJg_gZTwhOeYMwGWjRgQmqtfgfI_8Adhy1Vg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76060413</pqid></control><display><type>article</type><title>Immunohistochemical Characterization of Hepatic Lymphocytes in Primary Biliary Cirrhosis in Comparison With Primary Sclerosing Cholangitis and Autoimmune Chronic Active Hepatitis</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>HASHIMOTO, ETSUKO ; LINDOR, KEITH D. ; HOMBURGER, HENRY A. ; DICKSON, E. ROLLAND ; CZAJA, ALBERT J. ; WIESNER, RUSSELL H. ; LUDWIG, JURGEN</creator><creatorcontrib>HASHIMOTO, ETSUKO ; LINDOR, KEITH D. ; HOMBURGER, HENRY A. ; DICKSON, E. ROLLAND ; CZAJA, ALBERT J. ; WIESNER, RUSSELL H. ; LUDWIG, JURGEN</creatorcontrib><description>We analyzed the immunophenotypes of hepatic cellular infiltrates by quantitative immunohistochemical methods in biopsy specimens from 20 patients with primary biliary cirrhosis (PBC), 19 with primary sclerosing cholangitis, and 11 with autoimmune chronic active hepatitis. Specifically, we sought to identify activated T cells, interferon-γ-producing cells, and natural killer cells. The portal cellular infiltrate in PBC contained a preponderance of CD4 cells in comparison with CD8 cells, with a CD4/CD8 ratio of 2.45:1. The cellular infiltrate in areas of piecemeal necrosis contained mostly CD8 cells. Infiltrating CD8 cells in PBC had the surface phenotype of cytotoxic (CD8-positive, CD11b-negative) cells. Approximately 4% of T cells expressed interleukin 2 receptors. Interferon-γ-staining cells were rarely identified (in less than 2%). cells that expressed the natural killer cell markers CD16, CD56, or CD57 were infrequent, constituting approximately 5% of the cellular infiltrate. The composition of the infiltrates was similar in patients with PBC and chronic active hepatitis. Natural killer cells were twice as common in patients with primary sclerosing cholangitis (P&lt;0.05) as in those with PBC. The inflammatory infiltrates in areas of piecemeal necrosis were similar in the three diseases and differed from those found within the portal area, in that CD8 cells were preponderant. In all three liver diseases, almost 90% of bile ducts expressed class II HLA antigens. These findings support the hypothesis that cytotoxic T cells of either the CD4 or CD8 immunophenotype but not natural killer cells may be involved in the pathogenesis of PBC and chronic active hepatitis. We were unable to identify interferon-γ-producing cells in the inflammatory infiltrates; thus, we cannot conclude that this mechanism is responsible for aberrant expression of class II HLA antigens on bile duct cells.</description><identifier>ISSN: 0025-6196</identifier><identifier>EISSN: 1942-5546</identifier><identifier>DOI: 10.1016/S0025-6196(12)60897-0</identifier><identifier>PMID: 8231268</identifier><identifier>CODEN: MACPAJ</identifier><language>eng</language><publisher>Rochester, MN: Elsevier Inc</publisher><subject>Adult ; Autoimmune Diseases - immunology ; Autoimmune Diseases - metabolism ; Bile Ducts - immunology ; Bile Ducts - metabolism ; Biological and medical sciences ; Cholangitis, Sclerosing - immunology ; Cholangitis, Sclerosing - metabolism ; Gastroenterology. Liver. Pancreas. Abdomen ; Hepatitis, Chronic - immunology ; Hepatitis, Chronic - metabolism ; Humans ; Immunohistochemistry ; Interferon-gamma - biosynthesis ; Killer Cells, Natural - metabolism ; Liver - immunology ; Liver - metabolism ; Liver Cirrhosis, Biliary - immunology ; Liver Cirrhosis, Biliary - metabolism ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Lymphocytes - metabolism ; Medical sciences ; Middle Aged ; Other diseases. Semiology ; T-Lymphocytes - metabolism</subject><ispartof>Mayo Clinic proceedings, 1993-11, Vol.68 (11), p.1049-1055</ispartof><rights>1993 Mayo Foundation for Medical Education and Research</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-698cb3ac426b6a72ba1039e55c2d8fa8c33e80b747f4f67a85574a10a6b2ad973</citedby><cites>FETCH-LOGICAL-c389t-698cb3ac426b6a72ba1039e55c2d8fa8c33e80b747f4f67a85574a10a6b2ad973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3823697$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8231268$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HASHIMOTO, ETSUKO</creatorcontrib><creatorcontrib>LINDOR, KEITH D.</creatorcontrib><creatorcontrib>HOMBURGER, HENRY A.</creatorcontrib><creatorcontrib>DICKSON, E. ROLLAND</creatorcontrib><creatorcontrib>CZAJA, ALBERT J.</creatorcontrib><creatorcontrib>WIESNER, RUSSELL H.</creatorcontrib><creatorcontrib>LUDWIG, JURGEN</creatorcontrib><title>Immunohistochemical Characterization of Hepatic Lymphocytes in Primary Biliary Cirrhosis in Comparison With Primary Sclerosing Cholangitis and Autoimmune Chronic Active Hepatitis</title><title>Mayo Clinic proceedings</title><addtitle>Mayo Clin Proc</addtitle><description>We analyzed the immunophenotypes of hepatic cellular infiltrates by quantitative immunohistochemical methods in biopsy specimens from 20 patients with primary biliary cirrhosis (PBC), 19 with primary sclerosing cholangitis, and 11 with autoimmune chronic active hepatitis. Specifically, we sought to identify activated T cells, interferon-γ-producing cells, and natural killer cells. The portal cellular infiltrate in PBC contained a preponderance of CD4 cells in comparison with CD8 cells, with a CD4/CD8 ratio of 2.45:1. The cellular infiltrate in areas of piecemeal necrosis contained mostly CD8 cells. Infiltrating CD8 cells in PBC had the surface phenotype of cytotoxic (CD8-positive, CD11b-negative) cells. Approximately 4% of T cells expressed interleukin 2 receptors. Interferon-γ-staining cells were rarely identified (in less than 2%). cells that expressed the natural killer cell markers CD16, CD56, or CD57 were infrequent, constituting approximately 5% of the cellular infiltrate. The composition of the infiltrates was similar in patients with PBC and chronic active hepatitis. Natural killer cells were twice as common in patients with primary sclerosing cholangitis (P&lt;0.05) as in those with PBC. The inflammatory infiltrates in areas of piecemeal necrosis were similar in the three diseases and differed from those found within the portal area, in that CD8 cells were preponderant. In all three liver diseases, almost 90% of bile ducts expressed class II HLA antigens. These findings support the hypothesis that cytotoxic T cells of either the CD4 or CD8 immunophenotype but not natural killer cells may be involved in the pathogenesis of PBC and chronic active hepatitis. We were unable to identify interferon-γ-producing cells in the inflammatory infiltrates; thus, we cannot conclude that this mechanism is responsible for aberrant expression of class II HLA antigens on bile duct cells.</description><subject>Adult</subject><subject>Autoimmune Diseases - immunology</subject><subject>Autoimmune Diseases - metabolism</subject><subject>Bile Ducts - immunology</subject><subject>Bile Ducts - metabolism</subject><subject>Biological and medical sciences</subject><subject>Cholangitis, Sclerosing - immunology</subject><subject>Cholangitis, Sclerosing - metabolism</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Hepatitis, Chronic - immunology</subject><subject>Hepatitis, Chronic - metabolism</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Interferon-gamma - biosynthesis</subject><subject>Killer Cells, Natural - metabolism</subject><subject>Liver - immunology</subject><subject>Liver - metabolism</subject><subject>Liver Cirrhosis, Biliary - immunology</subject><subject>Liver Cirrhosis, Biliary - metabolism</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Lymphocytes - metabolism</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Other diseases. Semiology</subject><subject>T-Lymphocytes - metabolism</subject><issn>0025-6196</issn><issn>1942-5546</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkd2K1EAQhRtR1nH1ERZyIaIX0f5JOsmVzAb3BwYUVvGy6XQqm5IkHbs7C-Nj-YT2zIS59aoazldVp_oQcsXoR0aZ_PRAKc9TySr5nvEPkpZVkdJnZMOqjKd5nsnnZHNGXpJX3v-ilBZVlV2Qi5ILxmW5IX_vx3GZbI8-WNPDiEYPSd1rp00Ah390QDsltkvuYI5vk-z249xbsw_gE5ySbw5H7fbJNQ54qDU611uPR7G246wd-jjhJ4b-DD-YAVyEpse4yg56esQQO_TUJtslWDxYgig5O8WNWxPwCVYDkXtNXnR68PBmrZfkx82X7_Vduvt6e19vd6kRZRVSWZWmEdpkXDZSF7zRjIoK8tzwtux0aYSAkjZFVnRZJwtd5nmRRUbLhuu2KsQleXeaOzv7ewEf1IjewBD9gl28KiSVNGMigvkJNPEo76BT8-lQxag6ZKWOWalDEIpxdcxK0dh3tS5YmhHac9caTtTfrrr2MZbO6cmgP2MicvLo8_MJg_gZTwhOeYMwGWjRgQmqtfgfI_8Adhy1Vg</recordid><startdate>19931101</startdate><enddate>19931101</enddate><creator>HASHIMOTO, ETSUKO</creator><creator>LINDOR, KEITH D.</creator><creator>HOMBURGER, HENRY A.</creator><creator>DICKSON, E. ROLLAND</creator><creator>CZAJA, ALBERT J.</creator><creator>WIESNER, RUSSELL H.</creator><creator>LUDWIG, JURGEN</creator><general>Elsevier Inc</general><general>Mayo Medical Ventures</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19931101</creationdate><title>Immunohistochemical Characterization of Hepatic Lymphocytes in Primary Biliary Cirrhosis in Comparison With Primary Sclerosing Cholangitis and Autoimmune Chronic Active Hepatitis</title><author>HASHIMOTO, ETSUKO ; LINDOR, KEITH D. ; HOMBURGER, HENRY A. ; DICKSON, E. ROLLAND ; CZAJA, ALBERT J. ; WIESNER, RUSSELL H. ; LUDWIG, JURGEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-698cb3ac426b6a72ba1039e55c2d8fa8c33e80b747f4f67a85574a10a6b2ad973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Adult</topic><topic>Autoimmune Diseases - immunology</topic><topic>Autoimmune Diseases - metabolism</topic><topic>Bile Ducts - immunology</topic><topic>Bile Ducts - metabolism</topic><topic>Biological and medical sciences</topic><topic>Cholangitis, Sclerosing - immunology</topic><topic>Cholangitis, Sclerosing - metabolism</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Hepatitis, Chronic - immunology</topic><topic>Hepatitis, Chronic - metabolism</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Interferon-gamma - biosynthesis</topic><topic>Killer Cells, Natural - metabolism</topic><topic>Liver - immunology</topic><topic>Liver - metabolism</topic><topic>Liver Cirrhosis, Biliary - immunology</topic><topic>Liver Cirrhosis, Biliary - metabolism</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Lymphocytes - metabolism</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Other diseases. Semiology</topic><topic>T-Lymphocytes - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HASHIMOTO, ETSUKO</creatorcontrib><creatorcontrib>LINDOR, KEITH D.</creatorcontrib><creatorcontrib>HOMBURGER, HENRY A.</creatorcontrib><creatorcontrib>DICKSON, E. ROLLAND</creatorcontrib><creatorcontrib>CZAJA, ALBERT J.</creatorcontrib><creatorcontrib>WIESNER, RUSSELL H.</creatorcontrib><creatorcontrib>LUDWIG, JURGEN</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Mayo Clinic proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HASHIMOTO, ETSUKO</au><au>LINDOR, KEITH D.</au><au>HOMBURGER, HENRY A.</au><au>DICKSON, E. ROLLAND</au><au>CZAJA, ALBERT J.</au><au>WIESNER, RUSSELL H.</au><au>LUDWIG, JURGEN</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunohistochemical Characterization of Hepatic Lymphocytes in Primary Biliary Cirrhosis in Comparison With Primary Sclerosing Cholangitis and Autoimmune Chronic Active Hepatitis</atitle><jtitle>Mayo Clinic proceedings</jtitle><addtitle>Mayo Clin Proc</addtitle><date>1993-11-01</date><risdate>1993</risdate><volume>68</volume><issue>11</issue><spage>1049</spage><epage>1055</epage><pages>1049-1055</pages><issn>0025-6196</issn><eissn>1942-5546</eissn><coden>MACPAJ</coden><abstract>We analyzed the immunophenotypes of hepatic cellular infiltrates by quantitative immunohistochemical methods in biopsy specimens from 20 patients with primary biliary cirrhosis (PBC), 19 with primary sclerosing cholangitis, and 11 with autoimmune chronic active hepatitis. Specifically, we sought to identify activated T cells, interferon-γ-producing cells, and natural killer cells. The portal cellular infiltrate in PBC contained a preponderance of CD4 cells in comparison with CD8 cells, with a CD4/CD8 ratio of 2.45:1. The cellular infiltrate in areas of piecemeal necrosis contained mostly CD8 cells. Infiltrating CD8 cells in PBC had the surface phenotype of cytotoxic (CD8-positive, CD11b-negative) cells. Approximately 4% of T cells expressed interleukin 2 receptors. Interferon-γ-staining cells were rarely identified (in less than 2%). cells that expressed the natural killer cell markers CD16, CD56, or CD57 were infrequent, constituting approximately 5% of the cellular infiltrate. The composition of the infiltrates was similar in patients with PBC and chronic active hepatitis. Natural killer cells were twice as common in patients with primary sclerosing cholangitis (P&lt;0.05) as in those with PBC. The inflammatory infiltrates in areas of piecemeal necrosis were similar in the three diseases and differed from those found within the portal area, in that CD8 cells were preponderant. In all three liver diseases, almost 90% of bile ducts expressed class II HLA antigens. These findings support the hypothesis that cytotoxic T cells of either the CD4 or CD8 immunophenotype but not natural killer cells may be involved in the pathogenesis of PBC and chronic active hepatitis. We were unable to identify interferon-γ-producing cells in the inflammatory infiltrates; thus, we cannot conclude that this mechanism is responsible for aberrant expression of class II HLA antigens on bile duct cells.</abstract><cop>Rochester, MN</cop><pub>Elsevier Inc</pub><pmid>8231268</pmid><doi>10.1016/S0025-6196(12)60897-0</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0025-6196
ispartof Mayo Clinic proceedings, 1993-11, Vol.68 (11), p.1049-1055
issn 0025-6196
1942-5546
language eng
recordid cdi_proquest_miscellaneous_76060413
source MEDLINE; Alma/SFX Local Collection
subjects Adult
Autoimmune Diseases - immunology
Autoimmune Diseases - metabolism
Bile Ducts - immunology
Bile Ducts - metabolism
Biological and medical sciences
Cholangitis, Sclerosing - immunology
Cholangitis, Sclerosing - metabolism
Gastroenterology. Liver. Pancreas. Abdomen
Hepatitis, Chronic - immunology
Hepatitis, Chronic - metabolism
Humans
Immunohistochemistry
Interferon-gamma - biosynthesis
Killer Cells, Natural - metabolism
Liver - immunology
Liver - metabolism
Liver Cirrhosis, Biliary - immunology
Liver Cirrhosis, Biliary - metabolism
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Lymphocytes - metabolism
Medical sciences
Middle Aged
Other diseases. Semiology
T-Lymphocytes - metabolism
title Immunohistochemical Characterization of Hepatic Lymphocytes in Primary Biliary Cirrhosis in Comparison With Primary Sclerosing Cholangitis and Autoimmune Chronic Active Hepatitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T08%3A47%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunohistochemical%20Characterization%20of%20Hepatic%20Lymphocytes%20in%20Primary%20Biliary%20Cirrhosis%20in%20Comparison%20With%20Primary%20Sclerosing%20Cholangitis%20and%20Autoimmune%20Chronic%20Active%20Hepatitis&rft.jtitle=Mayo%20Clinic%20proceedings&rft.au=HASHIMOTO,%20ETSUKO&rft.date=1993-11-01&rft.volume=68&rft.issue=11&rft.spage=1049&rft.epage=1055&rft.pages=1049-1055&rft.issn=0025-6196&rft.eissn=1942-5546&rft.coden=MACPAJ&rft_id=info:doi/10.1016/S0025-6196(12)60897-0&rft_dat=%3Cproquest_cross%3E76060413%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76060413&rft_id=info:pmid/8231268&rft_els_id=S0025619612608970&rfr_iscdi=true